Wendy Stock to Drug Discovery
This is a "connection" page, showing publications Wendy Stock has written about Drug Discovery.
Connection Strength
0.649
-
Counterpoint: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML. Oncology (Williston Park). 2017 Mar 15; 31(3):190, 192.
Score: 0.531
-
Novel drug targets in acute leukemia. Clin Adv Hematol Oncol. 2015 Aug; 13(8):493-5.
Score: 0.119